TONIX PHARMACEUTICALS HOLDING CORP. (TNXP)

13.14USD -1.72% (-0.23)

Over 1M: +9.2%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

12 13 14
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Free Cash Flow: -29.7M Q3 '25 — Net Income: -32M Q4 '25 — Free Cash Flow: -41.5M Q4 '25 — Net Income: -46.9M Q1 '26 — Free Cash Flow: -44M Q1 '26 — Net Income: -40.2M Q2 '26 — Free Cash Flow: -42.8M Q2 '26 — Net Income: -40.6M -40M -30M -20M -10M 0
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Gross Profit Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 27.3%
OE margin -570.6%
Oper. margin -568.4%
ROIC -443.4%
Accruals -2.6%
Gross margin 83.8%
EBITDA margin -561.1%
FCF margin -543.3%
OCF margin -525.7%
Profit margin -548.6%
ROA -62.8%
ROCE -74.1%
ROE -71.8%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.7
EV/Sales 1.1×
EV/OE -0.2×
P/B 1.0×
P/C 1.2×
FCF yield -70.2%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.2
RPO / sales 0.13×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA 6.0
Interest cover -1858.7×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 6.5×
Cash runway 1.2 yr
F-score 4.5 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -74.4%
Sales Q/Q +577.9%
Shares change +1057.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.